Header cover image

Italian Pharmaceuticals & Biotech Pure Equity Growth

Results

2

0 new

Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.

2 companies

Krystal Biotech

Market Cap: €10.2b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

1KRYS

€313.40

7D

4.0%

1Y

155.5%

Corcept Therapeutics

Market Cap: €8.8b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

1CORT

€75.64

7D

7.3%

1Y

21.6%